Clofazimine in the treatment of dapsone resistant leprosy. 1976

P M Taylor, and R Alexander

Dapsone resistant patients treated with clofazimine 100 mg daily show a consistent response to treatment. Concern is expressed regarding the prolonged persistence of viable organisms during treatment, with the attendant risk of further resistance developing. The importance of prevention of this problem is discussed.

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D002991 Clofazimine A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) B-663,G-30,320,Lamprene,N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine,B 663,B663,G 30,320,G30,320
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P M Taylor, and R Alexander
September 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
P M Taylor, and R Alexander
September 1988, Leprosy review,
P M Taylor, and R Alexander
May 1972, The American journal of tropical medicine and hygiene,
P M Taylor, and R Alexander
June 1984, Leprosy review,
P M Taylor, and R Alexander
July 1973, Proceedings of the Royal Society of Medicine,
P M Taylor, and R Alexander
June 1983, Leprosy review,
P M Taylor, and R Alexander
June 1977, Leprosy review,
P M Taylor, and R Alexander
September 1983, Leprosy review,
P M Taylor, and R Alexander
September 1979, Leprosy review,
P M Taylor, and R Alexander
November 1975, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!